- $890 MnWorld market, 2023
- $2.8 BnProjected, 2033
- 12%Growth a year (CAGR)
- –Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$374 Mn
10% a year · 42% of the world -
2
China
$72 Mn
13.5% a year · 8% of the world -
3
Canada
$71 Mn
12% a year · 8% of the world -
4
Japan
$55 Mn
12.5% a year · 6.2% of the world -
5
Germany
$33 Mn
10.2% a year · 3.7% of the world -
6
France
$25 Mn
11% a year · 2.8% of the world -
7
UK
$23 Mn
10% a year · 2.6% of the world -
8
Brazil
$22 Mn
13% a year · 2.5% of the world -
9
Italy
$21 Mn
11.5% a year · 2.4% of the world -
10
Ecuador
$18 Mn
12.6% a year · 2% of the world
Insulin Patch Pumps by country and region
Spain
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 137 papers since 2021
- Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes: A Real World Observational Study of Available Systems. The Australian & New Zealand journal of obstetrics & gynaecology, 2026
- High Diagnostic Yield of Testing With a Diabetes Device Screening Series in Patients With Suspected Allergic Reactions to Glucose Sensors, Insulin Patch Pumps and Insulin Infusion Sets. Contact dermatitis, 2026
- Impact of DBLG1 Hybrid Closed-Loop Software Optimization and Meal Declaration Pattern on Glucose Metrics in Type 1 Diabetes: A 12-Month Prospective Evaluation in 2014 Users. Diabetes, obesity & metabolism, 2026
- Diabetes Distress in Caregivers of Young Children With Type 1 Diabetes Mellitus. Journal of diabetes science and technology, 2026
- Off-label Use of U-500 Regular Insulin with a Tubeless Automated Insulin Delivery System in Type 1 Diabetes and Severe Insulin Resistance: A Case Report. Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
Patients: Diabetes (adults)
| Place | Value | Year |
|---|---|---|
| World | 14.1 | 2022 |
| Australia | 8.1 | 2022 |
| Brazil | 12.9 | 2022 |
| Canada | 6.8 | 2022 |
| China | 11.2 | 2022 |
| Ecuador | 12.7 | 2022 |
| Egypt | 27.8 | 2022 |
| France | 2.7 | 2022 |
| Germany | 6.6 | 2022 |
| India | 22.6 | 2022 |
| Italy | 7.2 | 2022 |
| Japan | 6.4 | 2022 |
| Kenya | 5.6 | 2022 |
| Malaysia | 26.7 | 2022 |
| Mexico | 14.3 | 2022 |
| New Zealand | 9.0 | 2022 |
| Philippines | 13.2 | 2022 |
| Russia | 8.1 | 2022 |
| Saudi Arabia | 20.8 | 2022 |
| Singapore | 13.1 | 2022 |
| South Africa | 13.9 | 2022 |
| Spain | 3.6 | 2022 |
| Thailand | 12.3 | 2022 |
| UAE | 26.1 | 2022 |
| UK | 8.8 | 2022 |
| US | 12.5 | 2022 |
Compare Insulin Patch Pumps side by side
Key companies in Insulin Patch Pumps
Medtronic
Becton Dickinson and Company
Tandem Diabetes Care
Valeritas
CeQur
Hoffmann-La Roche AG
Cellnovo Group SA
DexCom Inc.
Quick answers
How big is the Insulin Patch Pumps market?
The world Insulin Patch Pumps market was worth about $890 Mn in 2023 and is projected to reach $2.8 Bn by 2033, growing 12% a year (CAGR).
Which country has the largest Insulin Patch Pumps market?
The US is the largest of the 24 countries we cover, at $374 Mn in 2023. India grows fastest, at 15% a year.
How much research is published on Insulin Patch Pumps?
PubMed lists about 137 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Patients: WHO Global Health Observatory. Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.